1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Akanda Corp.

Akanda Corp.

AKAN
Akanda Corp.US flagNASDAQ Capital Market
8.48
USD
+0.52
- -
274,464.00Market Cap
Akanda Corp.
AKAN
(NASDAQ Capital Market)

Recent

price

8.48

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
FRC
- -
4.02
80.76
4,259.65
423.68
- -
84.23
Revenue per Share
-2,718.6
-4,484.54
-15,850.29
-18,955.57
-32,275.07
-140.67
-14,900.11
Basic EPS, GAAP
-2,589.18
-3,492.41
-13,905.52
-19,155.03
-1,502.08
-208.76
-2,598.92
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-10,060.54
-11,770.36
46,092.24
-2,342.91
201.27
-2,768.86
Book Value per Share
- -
-10,435.38
-4,796.34
7,628.56
-7,628.57
146.33
-3,913.33
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
3
- -
- -
- -
Sales/Revenue/Turnover
- -
-80,781.04
-6,203.45
-770.18
-863.57
- -
-1,930.99
Operating Margin (%)
- -
- -
- -
4
- -
- -
- -
Depreciation Expense
-1
-2
-8
-12
-32
-4
-46
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-111,569.88
-19,625.88
-445
-7,617.74
- -
-17,690.19
Profit Margin (%)
- -
-3
-4
-6
-8
1
-3
Working Capital
- -
7
2
3
2
- -
12
LT Debt
- -
-5
-2
27
-4
4
-12
Total Equity
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-416.9%
-380.38%
Free Cash Flow
- -
122.34%
31%
Net Income, GAAP
- -
280.19%
1,014.59%
Sales/Revenue/Turnover
- -
- -
-39.09%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-32,275.07
2024
- -
- -
- -
- -
-140.67
2025
- -
- -
- -
- -
-14,900.11

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Karo Pharma AB (publ) (KARO.ST)
Aquestive Therapeutics, Inc. (AQST)
Perrigo Company plc (PRGO)
Lucy Scientific Discovery Inc. (LSDI)
Captiva Verde Wellness Corp. (PWR.CN)
Alliance Growers Corp. (ALGWF)
Business
Akanda Corp. is a diversified company primarily engaged in the cultivation, manufacture, and distribution of cannabis-based products including medical cannabis and cannabinoid formulations. The company originally focused on premium quality medical cannabis products and cultivation operations in Canada and the UK. Recently, Akanda completed a strategic reverse merger with First Towers & Fiber Corp., a Mexican telecommunications infrastructure firm, substantially expanding its business into the telecommunications sector. This acquisition added over 30 operational revenue-generating cellular towers and a 700-kilometer dark fiber network in Mexico, with plans to further expand by up to 20 additional towers by the end of 2025 to increase network capacity and recurring revenue. Akanda also announced plans to develop THC and CBD farming facilities in Canada, marking an expansion in its cannabis cultivation and processing capabilities. Founded in 2021 and headquartered in London, United Kingdom, the company has shifted from a pre-revenue cannabis enterprise toward a diversified model that integrates telecommunications infrastructure in North America, targeting markets in Canada and Mexico. This strategic diversification aligns with Akanda's recent operational focus on telecom infrastructure growth while maintaining its ongoing cannabis product development efforts.

Company News

APIChatGPT

  • newsfilecorp.com

    Coloured Ties Capital Announces Proposed Share Consolidation

  • newsfilecorp.com

    Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement

  • newsfilecorp.com

    Akanda Corp. Regains Compliance with Nasdaq Periodic Filing Requirement

  • newsfilecorp.com

    Akanda Corp. Announces Receipt of NASDAQ Noncompliance Letter

  • newsfilecorp.com

    Akanda Corp. Announces Cancellation of Special Meeting

  • newsfilecorp.com

    Akanda Adjourns Special Meeting of Shareholders

  • defenseworld.net

    Akanda Corp. (NASDAQ:AKAN) Short Interest Down 80.7% in April

  • defenseworld.net

    Critical Analysis: Akanda (NASDAQ:AKAN) and Cerus (NASDAQ:CERS)

  • newsfilecorp.com

    Akanda Corp. Announces Reverse Stock Split

  • newsfilecorp.com

    Akanda Adjourns Shareholder Meeting

  • defenseworld.net

    Reviewing Oramed Pharmaceuticals (NASDAQ:ORMP) & Akanda (NASDAQ:AKAN)

  • defenseworld.net

    Akanda Corp. (NASDAQ:AKAN) Short Interest Down 34.3% in March

  • newsfilecorp.com

    Akanda Corp. Driving Recurring Revenue Growth: $2 Million Cash Flow Secured Through Fiber Acquisition

  • newsfilecorp.com

    First Towers & Fiber Corp. Owns the Largest Dark Fiber Network in Central Mexico

  • newsfilecorp.com

    Akanda Announces Closing of $7.0 Million Convertible Note Offering

  • newsfilecorp.com

    Akanda Announces $7.0 Million Convertible Note Offering

  • defenseworld.net

    Akanda Corp. (NASDAQ:AKAN) Sees Large Decrease in Short Interest

  • newsfilecorp.com

    Akanda Corp. Announces Reverse Stock Split

  • newsfilecorp.com

    Akanda Corp. Welcomes Momentum Towards Cannabis Reform in the United States

  • accessnewswire.com

    Akanda Is Slowly Controlling the Map Behind Mexico's Telecom Boom